NASDAQ: ZIMV
Zimvie Inc Stock

$13.09-0.26 (-1.95%)
Updated Feb 11, 2025
ZIMV Price
$13.09
Fair Value Price
-$12.34
Market Cap
$361.27M
52 Week Low
$13.01
52 Week High
$22.40
P/E
-0.99x
P/B
0.89x
P/S
3.07x
PEG
N/A
Dividend Yield
N/A
Revenue
$142.47M
Earnings
-$348.91M
Gross Margin
44%
Operating Margin
-215.48%
Profit Margin
-244.9%
Debt to Equity
0.93
Operating Cash Flow
$14M
Beta
1.38
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ZIMV Overview

ZimVie Incorporated develops and manufactures products and solutions to treat a range of spine pathologies and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic products, surgical instrumentation; bone grafts, barrier membrane ,allograft, and collagen wound care products; intraoral scanners; CAD/CAM workflow systems; and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures. The company also provides MIS solutions and motion preservation solutions. ZimVie Inc. was founded in 2021 and is headquartered in Westminster, CO.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ZIMV's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

B
Value
B
Growth
D
Momentum
C
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
D
ZIMV
Ranked
#27 of 127

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$29.20A
$10.68A
$47.83A
View Top Medical Device Stocks

Be the first to know about important ZIMV news, forecast changes, insider trades & much more!

ZIMV News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ZIMV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ZIMV ($13.09) is overvalued by 206.09% relative to our estimate of its Fair Value price of -$12.34 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ZIMV ($13.09) is not significantly undervalued (206.09%) relative to our estimate of its Fair Value price of -$12.34 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ZIMV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ZIMV due diligence checks available for Premium users.

Valuation

ZIMV fair value

Fair Value of ZIMV stock based on Discounted Cash Flow (DCF)

Price
$13.09
Fair Value
-$12.34
Undervalued by
206.09%
ZIMV ($13.09) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ZIMV ($13.09) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ZIMV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ZIMV price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.99x
Industry
41.14x
Market
31.02x

ZIMV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.89x
Industry
4.35x
ZIMV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ZIMV's financial health

Profit margin

Revenue
$103.2M
Net Income
-$2.3M
Profit Margin
-2.2%
ZIMV's Earnings (EBIT) of -$306.99M... subscribe to Premium to read more.
Interest Coverage Financials
ZIMV's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$782.9M
Liabilities
$376.3M
Debt to equity
0.93
ZIMV's short-term assets ($265.67M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZIMV's short-term assets ($265.67M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZIMV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$1.2M
Investing
-$530.0k
Financing
-$18.8M
ZIMV's operating cash flow ($14.18M)... subscribe to Premium to read more.
Debt Coverage Financials

ZIMV vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ZIMVB$361.27M-1.95%-0.99x0.89x
PACBF$364.24M0.00%-0.91x0.80x
NPCEC$367.13M-1.76%-12.42x37.37x
CVRXC$353.52M-2.15%-5.40x5.42x
SMLRC$341.37M-5.30%20.43x4.00x

Zimvie Stock FAQ

What is Zimvie's quote symbol?

(NASDAQ: ZIMV) Zimvie trades on the NASDAQ under the ticker symbol ZIMV. Zimvie stock quotes can also be displayed as NASDAQ: ZIMV.

If you're new to stock investing, here's how to buy Zimvie stock.

What is the 52 week high and low for Zimvie (NASDAQ: ZIMV)?

(NASDAQ: ZIMV) Zimvie's 52-week high was $22.40, and its 52-week low was $13.01. It is currently -41.56% from its 52-week high and 0.61% from its 52-week low.

How much is Zimvie stock worth today?

(NASDAQ: ZIMV) Zimvie currently has 27,598,871 outstanding shares. With Zimvie stock trading at $13.09 per share, the total value of Zimvie stock (market capitalization) is $361.27M.

Zimvie stock was originally listed at a price of $25.53 in Mar 1, 2022. If you had invested in Zimvie stock at $25.53, your return over the last 2 years would have been -48.73%, for an annualized return of -28.39% (not including any dividends or dividend reinvestments).

How much is Zimvie's stock price per share?

(NASDAQ: ZIMV) Zimvie stock price per share is $13.09 today (as of Feb 11, 2025).

What is Zimvie's Market Cap?

(NASDAQ: ZIMV) Zimvie's market cap is $361.27M, as of Feb 12, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Zimvie's market cap is calculated by multiplying ZIMV's current stock price of $13.09 by ZIMV's total outstanding shares of 27,598,871.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.